M&M, Lupin and JSW Energy to see some action today

13 Nov 2025 Evaluate

Mahindra & Mahindra (M&M) and Manulife have entered into an agreement to establish a 50:50 life insurance joint venture, subject to regulatory approval. This new venture will strengthen Mahindra and Manulife’s existing footprint in India and underscores their commitment to enhancing the financial wellbeing of customers in one of the world’s fastest-growing markets. The vision is to be the number one life insurance company for rural and semi-urban India, and in serving urban customers through leadership in protection solutions.  

Lupin has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Chhatrapati Sambhajinagar (Aurangabad) facility, following a product-specific Pre-Approval Inspection from September 1, 2025 to September 5, 2025. This underscores the company’s commitment to upholding the highest standards of quality and compliance, and delivering trusted healthcare solutions to patients worldwide.

JSW Energy has raised Rs 250 crore through the allotment of 25,000 Unsecured, Listed, Rated, Taxable, Redeemable Non-Convertible Debentures (NCDs) bearing a face value of Rs 1,00,000 each, on a private placement basis. The Finance Committee, at its meeting held on November 12, 2025, has allotted the same. 

Omaxe has planned to acquire the 100% equity shareholding of Next10 Realbuild and Next10 Land Developers (collectively referred to as the ‘Target Companies’). Further, upon completion of the above acquisitions, the Target Companies shall become Wholly Owned Subsidiaries of Omaxe. The Target Companies belongs to Real Estate Industry.  

Mukka Proteins has received approval for to make a strategic investment in United Gulf Fishery Products LLC (the Investee Company) by acquiring and/or subscribing to the shares for an amount not exceeding Rs 1 crore equivalent to 68% of the capital of the Investee Company in one or more tranches. The Board of Directors of the company at its meeting held on November 12, 2025, has approved the same. 

Sansera Engineering has received approval for additional investment of Rs 30 crore in MMRFIC Technology (MMRFIC). The Board of Directors of the company at its meeting held on November 12, 2025, has approved the same. 

Auro Laboratories has successfully completed World Health Organization (WHO) inspection at its Active Pharmaceutical Ingredients (API) (Bulk Drugs) manufacturing located in MIDC Tarapur, Maharashtra. The Company has received World Health Organization - Good Manufacturing Practices (WHO - GMP) Certificate from the Food & Drug Administration, Maharashtra and is valid upto September 30, 2028.

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×